Archive - June 2022
Novartis announces promising five-year data for leukaemia treatment Kymriah
New virtual health and care report from WHO and Novartis calls for ‘critical action’
Eli Lilly’s Verzenios recommended by NICE as combination therapy for early-stage breast cancer
UK report suggests last winter’s Omicron strain was less likely to cause ‘long COVID’
Novartis receives vital licence for Scemblix
NICE recommends Eli Lilly’s breast cancer therapy
Omicron Less Likely To Cause Long COVID: UK Study
CDC Issues Safer Sex Guidelines Amid Monkeypox Outbreak